208 related articles for article (PubMed ID: 17990101)
1. JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer.
Reedijk M; Pinnaduwage D; Dickson BC; Mulligan AM; Zhang H; Bull SB; O'Malley FP; Egan SE; Andrulis IL
Breast Cancer Res Treat; 2008 Oct; 111(3):439-48. PubMed ID: 17990101
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer.
Cohen B; Shimizu M; Izrailit J; Ng NF; Buchman Y; Pan JG; Dering J; Reedijk M
Breast Cancer Res Treat; 2010 Aug; 123(1):113-24. PubMed ID: 19915977
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
4. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival.
Reedijk M; Odorcic S; Chang L; Zhang H; Miller N; McCready DR; Lockwood G; Egan SE
Cancer Res; 2005 Sep; 65(18):8530-7. PubMed ID: 16166334
[TBL] [Abstract][Full Text] [Related]
5. Notch-1 and notch-4 receptors as prognostic markers in breast cancer.
Yao K; Rizzo P; Rajan P; Albain K; Rychlik K; Shah S; Miele L
Int J Surg Pathol; 2011 Oct; 19(5):607-13. PubMed ID: 20444726
[TBL] [Abstract][Full Text] [Related]
6. High-level JAG1 mRNA and protein predict poor outcome in breast cancer.
Dickson BC; Mulligan AM; Zhang H; Lockwood G; O'Malley FP; Egan SE; Reedijk M
Mod Pathol; 2007 Jun; 20(6):685-93. PubMed ID: 17507991
[TBL] [Abstract][Full Text] [Related]
7. [Notch signaling in human breast cancer].
Dong XB; Ji CY; Ma DX; Ma R; Zang SL; Yu HQ; Guo DM
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):425-8. PubMed ID: 17974275
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator uPA is a direct transcriptional target of the JAG1-Notch receptor signaling pathway in breast cancer.
Shimizu M; Cohen B; Goldvasser P; Berman H; Virtanen C; Reedijk M
Cancer Res; 2011 Jan; 71(1):277-86. PubMed ID: 21199807
[TBL] [Abstract][Full Text] [Related]
9. Protein and mRNA expression of notch pathway components in operable tumors of patients with laryngeal cancer.
Krikelis D; Kotoula V; Bobos M; Fountzilas E; Markou K; Karasmanis I; Angouridakis N; Vlachtsis K; Kalogeras KT; Nikolaou A; Fountzilas G
Anticancer Res; 2014 Nov; 34(11):6495-503. PubMed ID: 25368251
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
11. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
[TBL] [Abstract][Full Text] [Related]
12. JAG1 Is Associated with Poor Survival through Inducing Metastasis in Lung Cancer.
Chang WH; Ho BC; Hsiao YJ; Chen JS; Yeh CH; Chen HY; Chang GC; Su KY; Yu SL
PLoS One; 2016; 11(3):e0150355. PubMed ID: 26930648
[TBL] [Abstract][Full Text] [Related]
13. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
[TBL] [Abstract][Full Text] [Related]
14. Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer.
Mulligan AM; O'Malley FP; Ennis M; Fantus IG; Goodwin PJ
Breast Cancer Res Treat; 2007 Nov; 106(1):39-47. PubMed ID: 17221153
[TBL] [Abstract][Full Text] [Related]
15. Notch1 pathway in adrenocortical carcinomas: correlations with clinical outcome.
Ronchi CL; Sbiera S; Altieri B; Steinhauer S; Wild V; Bekteshi M; Kroiss M; Fassnacht M; Allolio B
Endocr Relat Cancer; 2015 Aug; 22(4):531-43. PubMed ID: 25979380
[TBL] [Abstract][Full Text] [Related]
16. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
Ignatiadis M; Xenidis N; Perraki M; Apostolaki S; Politaki E; Kafousi M; Stathopoulos EN; Stathopoulou A; Lianidou E; Chlouverakis G; Sotiriou C; Georgoulias V; Mavroudis D
J Clin Oncol; 2007 Nov; 25(33):5194-202. PubMed ID: 17954712
[TBL] [Abstract][Full Text] [Related]
17. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.
Razis E; Kalogeras KT; Kotoula V; Eleftheraki AG; Nikitas N; Kronenwett R; Timotheadou E; Christodoulou C; Pectasides D; Gogas H; Wirtz RM; Makatsoris T; Bafaloukos D; Aravantinos G; Televantou D; Pavlidis N; Fountzilas G
Clin Breast Cancer; 2012 Jun; 12(3):183-93. PubMed ID: 22607768
[TBL] [Abstract][Full Text] [Related]
18. NOTCH1, NOTCH3, NOTCH4, and JAG2 protein levels in human endometrial cancer.
Sasnauskienė A; Jonušienė V; Krikštaponienė A; Butkytė S; Dabkevičienė D; Kanopienė D; Kazbarienė B; Didžiapetrienė J
Medicina (Kaunas); 2014; 50(1):14-8. PubMed ID: 25060200
[TBL] [Abstract][Full Text] [Related]
19. [Expression of JAG1 and DLL1 genes in colorectal cancer and its clinical significance].
Jin HY; Xu JH; Wang XF; Ding YJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Apr; 15(4):396-9. PubMed ID: 22539391
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor expression in male breast cancer predicts inferior outcome and poor response to tamoxifen treatment.
Wenhui Z; Shuo L; Dabei T; Ying P; Zhipeng W; Lei Z; Xiaohui H; Jingshu G; Hongtao S; Qingyuan Z
Eur J Endocrinol; 2014 Oct; 171(4):527-33. PubMed ID: 25069458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
